ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619102 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619102; 2) Community: the network communities that were significantly associated with the response to NSC 619102; 3) Molecule: the relationships between components within communities and NSC 619102; 4) MDR: the compounds that were significantly associated with the NSC 619102.

NSC Compound Enrichment Correlation
NSC 701022 Null 0.0480633950058475 0.12403235
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0480633950058475 0.47265613
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0480633950058475 0.10877719
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0480633950058475 0.23183535
NSC 733149 Null 0.0480633950058475 0.29323031
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 0.45139151
NSC 743532 Null 0.0480633950058475 0.25465832
NSC 752761 Null 0.0480633950058475 -0.077903091
NSC 755880 Mitomycin (USAN) 0.0480633950058475 -0.1122924
NSC 758670 TANNIC ACID 0.0480633950058475 -0.26735052
Total:82  Current:81    [First] [Prev] [Next] [Last]